CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Novartis Pharmaceuticals Corporation v. Dr. Reddy's Laboratories Ltd.

1:14-cv-00387

Overview

Case Number 1:14-cv-00387
Filing Date 2014-03-26
Status Terminated
Termination Date 2015-06-22
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Dr. Reddy's Laboratories Inc. Operating Company

Represented By

2 Attorneys Listed

Robert Karl Beste , III

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

The Corporate Plaza, 800 Delaware Ave.

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Dr. Reddy's Laboratories Ltd. Operating Company

Represented By

3 Attorneys Listed

Robert Karl Beste , III

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

The Corporate Plaza, 800 Delaware Ave.

Constance S. Huttner

Email: chuttner@windelsmarx.com

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Plaintiff

Novartis AG Operating Company

Represented By

2 Attorneys Listed

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Novartis Pharmaceuticals Corporation Operating Company

Represented By

3 Attorneys Listed

David K. Barr

Email: david.barr@arnoldporter.com

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
USRE43932
Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
Filed: 2011-09-21
Issued: 2013-01-15
Active (4.8 yrs remaining)
Expires: 2031-09-21

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

14

Dispositive

0

Granted

0

Denied

0

Pending / Review

7

Motions by Category

Procedural / Extension Motion 14

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
SO ORDERED, re (24 in 1:14-cv-00157-LPS, 15 in 1:14-cv-01076-LPS, 19 in 1:14-cv-00387-LPS, 13 in 1:14-cv-01283-LPS) STIPULATION TO EXTEND TIME regarding the Dea...
Entry #— • 2015-05-06
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME regarding the Deadline for the Parties to Submit a Proposed Scheduling Order to Wednesday, July 8, 2015 (from Friday, May 8, 2015) - ...
Entry #19 • 2015-05-05 Document →
Procedural / Extension Motion Pending
SO ORDERED, re (18 in 1:14-cv-00387-LPS, 23 in 1:14-cv-00157-LPS, 14 in 1:14-cv-01076-LPS, 12 in 1:14-cv-01283-LPS) STIPULATION TO EXTEND TIME for the Parties t...
Entry #— • 2015-02-27
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the Parties to Submit a Proposed Scheduling Order to Friday, May 8, 2015 (from Monday, March 9, 2015 in C.A. No. 14-157 and Monda...
Entry #18 • 2015-02-26 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 14 STIPULATION TO EXTEND TIME time for defendants to move, answer, or otherwise respond to the Complaint to October 27, 2014 filed by Dr. Reddy's...
Entry #— • 2014-08-28
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME time for defendants to move, answer, or otherwise respond to the Complaint to October 27, 2014 - filed by Dr. Reddy's Laboratories In...
Entry #14 • 2014-08-27 Document →

Docket Entries

(37 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1486647.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 03/27/2014)

Entry #1 • 2014-03-26
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 03/27/2014)

Entry #2 • 2014-03-26
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/25/14. Date of Expiration of Patent: 1/16/19 and 7/16/19.Thirty Month Stay Deadline: 8/26/2016. (dmp, ) (Entered: 03/27/2014)

Entry #3 • 2014-03-26
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE43,932;. (dmp, ) (Entered: 03/27/2014)

Entry #4 • 2014-03-26
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (dmp, ) (Entered: 03/27/2014)

Entry #5 • 2014-03-26
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc